Initial work revealed overexpression of SETD8 in a wide range of cancers such as bladder cancer, non-small and small lung carcinoma, chronic myeloid leukemia, hepatocellular carcinoma and pancreatic cancer, where, as mentioned, its expression correlates with the levels of the DNA replication factor PCNA [8]. Here, KMT5A is linked to cancer.